摘要 |
Novel oxoisoindoline sulfonamide integrase inhibitors are useful to inhibit HIV activity, and are therefore suitable for treatment or prophylaxis of HIV infection, for example in the treatment or prevention of AIDS. In particular embodiments, the inhibitors are oxoisoindoline-4- sulfonamides, such as 6,7- dihydroxy- 1 -oxoisomdolirie-4-sulfonamides. |
申请人 |
THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES;ZHAO, XUE, ZHI;HUGHES, STEPHEN, H.;VU, BAO-HAN, CHRISTIE;SMITH, STEVEN;JOHNSON, BARRY;POMMIER, YVES;BURKE, TERRENCE, R., JR. |
发明人 |
ZHAO, XUE, ZHI;HUGHES, STEPHEN, H.;VU, BAO-HAN, CHRISTIE;SMITH, STEVEN;JOHNSON, BARRY;POMMIER, YVES;BURKE, TERRENCE, R., JR. |